Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical Trials

IMPORTANCE: Migraine with aura may respond differently to therapies than migraine without aura. Individuals with migraine with aura have an elevated vascular risk, necessitating a safety assessment of migraine preventive treatments in this patient subgroup. OBJECTIVE: To assess the efficacy and safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashina, Messoud, Goadsby, Peter J., Dodick, David W., Tepper, Stewart J., Xue, Fei, Zhang, Feng, Brennan, Francis, Paiva da Silva Lima, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689443/
https://www.ncbi.nlm.nih.gov/pubmed/34928306
http://dx.doi.org/10.1001/jamaneurol.2021.4678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689443/
https://www.ncbi.nlm.nih.gov/pubmed/34928306
http://dx.doi.org/10.1001/jamaneurol.2021.4678

Ejemplares similares